• OPEN AN ACCOUNT
Indian Indices
Sensex
73,201.91 -507.78
( -0.69%)
Global Indices
Nasdaq
52,880.09 363.21
(0.69%)
Dow Jones
7,780.08 46.51
(0.60%)
Hang Seng
64,728.80 653.38
(1.02%)
Nikkei 225
10,751.68 18.68
(0.17%)
Forex
USD-INR
94.82 -0.08
(-0.09%)
EUR-INR
106.45 0.01
(0.01%)
GBP-INR
126.63 0.25
(0.20%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
44.9147092
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
4.86
15.02
EPS(TTM)
Face Value()
Div & Yield %
7.2
10
0
 

Swan Corp reports consolidated net profit of Rs 268.68 crore in the March 2026 quarter
Jun 01,2026
Net profit of Swan Corp reported to Rs 268.68 crore in the quarter ended March 2026 as against net loss of Rs 17.73 crore during the previous quarter ended March 2025. Sales rose 1.62% to Rs 869.65 crore in the quarter ended March 2026 as against Rs 855.75 crore during the previous quarter ended March 2025.

For the full year,net profit declined 63.71% to Rs 274.13 crore in the year ended March 2026 as against Rs 755.30 crore during the previous year ended March 2025. Sales declined 11.48% to Rs 4371.20 crore in the year ended March 2026 as against Rs 4937.87 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales869.65855.75 2 4371.204937.87 -11
OPM %-30.001.63 --4.66-2.86 -
PBDT358.9817.67 1932 488.851619.26 -70
PBT326.60-13.17 LP 364.951471.97 -75
NP268.68-17.73 LP 274.13755.30 -64